JAMIE LOBBENBERG: Open Payments
NPI 1265781207 · HARLEYSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 34 payments from 8 companies in 2025. Trend: 2023 $633 · 2024 $1,314 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $296 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $283 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 3 | $97 |
| Lundbeck LLC | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, REXULTI, COSENTYX, FANAPT, Qelbree, Sunosi.
Industry payments across PA — which companies pay providers there.
